Metformin preconditioning potentiates the remyelinating effects of adipose‐derived mesenchymal stem cells associated with decorin upregulation in a cuprizone model of demyelination
Year: 2026
Type: article
Abstract: BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). Changes in the microenvironment surrounding oligodendrocyte progenitor cells (OPCs), characterized by excessive production of extracellular matrix (ECM) components driven by elevated TGF-β and CTGF signaling, impair the remyelination capacity of these cells. Decorin (DCN), an endogenous inhibitor of the TGF-β/CTGF signaling axis, has emerged as a potential regulator of ECM homeostasis. METHODS: To improve the therapeutic outcomes of stem cell-based strategies, adipose-derived mesenchymal stem cells (ADMSCs) were preconditioned with metformin (MET) before transplantation into a C57BL/6 mouse model of cuprizone-induced demyelination. Cell viability and the expression of CXCR4 and SDF-1α were evaluated to determine the migratory potential following MET preconditioning. Remyelination and oligodendroglial lineage dynamics were assessed using Luxol Fast Blue (LFB) staining and analysis of MBP and NG2 expression. ECM remodeling and mechanosensitive signaling were evaluated through the expression of DCN, TGF-β, CTGF, and Piezo 1. RESULTS: MET preconditioning was optimized at 1 mmol/L for 24 h based on MTT assay results and increased the migratory potential of ADMSCs, as indicated by upregulation of the CXCR4/SDF-1α axis. Histological analysis revealed enhanced remyelination, accompanied by increased MBP and reduced NG2 expression in treated groups. At the molecular level, transplantation of MET-preconditioned ADMSCs upregulated DCN while downregulating TGF-β, CTGF, and Piezo 1 expression. CONCLUSION: MET preconditioning enhances the therapeutic efficacy of ADMSCs through increasing migration and homing of these cells and consequently promotes remyelination in a cuprizone-induced demyelination model, potentially through DCN-mediated mechanisms.
DOI: 10.1002/ame2.70296
Authors: Fatemeh Taghizadeh(Investigation, Methodology, Software, Writing – original draft), Parichehr Pasbakhsh(Conceptualization, Supervision, Writing – review & editing), Ameneh Alikarami(Investigation, Methodology, Validation), Golaleh Noorzehi(Data curation, Investigation, Methodology, Writing – original draft), Sina Mojaverrostami(Conceptualization, Project administration, Supervision), Iraj Ragerdi Kashani(Conceptualization, Project administration, Supervision)
Institution: Tehran University of Medical Sciences
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,000
Award: G9001395074
OpenAlex ID: W7235003553
